Cargando...
IPF clinical trial design and endpoints
PURPOSE OF REVIEW: There remains a dire need for therapies that impact the clinical course of patients with idiopathic pulmonary fibrosis (IPF). Indeed, there is a surge of interest in IPF therapeutics, with many candidate agents in various stages of development. Optimal design and implementation of...
Guardado en:
Autores principales: | , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4162322/ https://ncbi.nlm.nih.gov/pubmed/25022315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCP.0000000000000091 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|